Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (871-880 of 1,115) with videos related to

Pageof 112
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary resultsI F Khouri, M J Keating, H M Vriesendorp, et al.
Leukemia & Lymphoma|November 9, 2001
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndromeB S Dabaja, S M O'Brien, H M Kantarjian, et al.
Haematologica|August 26, 2003
The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylateSimona Gatto, Barbara Scappini, Lan Pham, et al.
Diabetes|April 8, 2017
Mechanisms Controlling Glucose-Induced GLP-1 Secretion in Human Small IntestineEmily W Sun, Dayan de Fontgalland, Philippa Rabbitt, et al.
Blood|August 2, 2011
The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemiaJulia Hoellenriegel, Sarah A Meadows, Mariela Sivina, et al.
Molecular and Cellular Endocrinology|September 22, 2023
Alterations in GLP-1 and PYY release with aging and body mass in the human gutLauren A Jones, Emily W Sun, Amanda L Lumsden, et al.
American Journal of Hematology|November 1, 1988
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working groupB D Cheson, J M Bennett, K R Rai, et al.
British Journal of Haematology|October 3, 2002
Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survivalFrancis J Giles, Hagop M Kantarjian, B Nebiyou Bekele, et al.
Blood|August 1, 2002
The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemiaAlessandra Ferrajoli, Michael J Keating, Taghi Manshouri, et al.
Journal of Neurochemistry|September 5, 2017
p75 neurotrophin receptor interacts with and promotes BACE1 localization in endosomes aggravating amyloidogenesisKhalil Saadipour, Noralyn B Mañucat-Tan, Yoon Lim, et al.
Pageof 112

Showing results (871-880 of 1,115) with videos related to

Sort By:
Pageof 112
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary resultsI F Khouri, M J Keating, H M Vriesendorp, et al.
Leukemia & Lymphoma|November 9, 2001
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndromeB S Dabaja, S M O'Brien, H M Kantarjian, et al.
Haematologica|August 26, 2003
The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylateSimona Gatto, Barbara Scappini, Lan Pham, et al.
Diabetes|April 8, 2017
Mechanisms Controlling Glucose-Induced GLP-1 Secretion in Human Small IntestineEmily W Sun, Dayan de Fontgalland, Philippa Rabbitt, et al.
Blood|August 2, 2011
The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemiaJulia Hoellenriegel, Sarah A Meadows, Mariela Sivina, et al.
Molecular and Cellular Endocrinology|September 22, 2023
Alterations in GLP-1 and PYY release with aging and body mass in the human gutLauren A Jones, Emily W Sun, Amanda L Lumsden, et al.
American Journal of Hematology|November 1, 1988
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working groupB D Cheson, J M Bennett, K R Rai, et al.
British Journal of Haematology|October 3, 2002
Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survivalFrancis J Giles, Hagop M Kantarjian, B Nebiyou Bekele, et al.
Blood|August 1, 2002
The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemiaAlessandra Ferrajoli, Michael J Keating, Taghi Manshouri, et al.
Journal of Neurochemistry|September 5, 2017
p75 neurotrophin receptor interacts with and promotes BACE1 localization in endosomes aggravating amyloidogenesisKhalil Saadipour, Noralyn B Mañucat-Tan, Yoon Lim, et al.
Pageof 112